XXXX ointment 0.05 percent in conjunction with UVB and tar in a modified outpatient Goeckerman regimen.

@entity1 @entity7864 @entity1569 @entity5658 @entity71773
Nineteen @entity1 with @entity1569 were treated with a modified Goeckerman regimen tailored to enhance @entity1 compliance. Treatment consisted of daily @entity7864 baths at bedtime, followed by the application of 0.05 percent @entity71773 ointment. @entity1 received increasing suberythemal dosages of short ultraviolet radiation (UVB) three times weekly at our outpatient phototherapy center. The duration of therapy ranged from three to twenty-eight weeks. The average number of phototherapy treatments was twenty-nine. Eight @entity1 had total clearing of their lesions. Of the remainder, seven had at least 75 percent clearing and one had less than 25 percent clearing of @entity1569 . One @entity1 with psoriatic @entity5658 experienced no improvement. Two @entity1 did not complete the study. There were no side effects encountered during treatment other than periodic excessive erythema. If the two @entity1 who did not complete the study are excluded from the results, 88 percent (fifteen of the remaining seventeen) had 75 percent or greater resolution of their psoriatic eruption and 47 percent (eight of seventeen) had total clearing. This outpatient modification of the Goeckerman regimen eliminates the use of cosmetically unacceptable topical agents during working hours, promotes @entity1 compliance, and presumably contributes to enhanced therapeutic efficacy.
